Compare, Analyse Biocon with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs MYLAN (US) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    MYLAN
EQUITY SHARE DATA
    BIOCON
Mar-19
MYLAN
Dec-18
BIOCON /
MYLAN
5-Yr Chart
Click to enlarge
High Rs7073,561-   
Low Rs5541,960-   
Sales per share (Unadj.) Rs91.91,638.8-  
Earnings per share (Unadj.) Rs16.744.5-  
Cash flow per share (Unadj.) Rs24.2351.3-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.61,772.8-  
Shares outstanding (eoy) m600.00514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.91.7 407.2%   
Avg P/E ratio x37.762.0 60.8%  
P/CF ratio (eoy) x26.17.9 331.9%  
Price / Book Value ratio x6.21.6 398.4%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,3301,420,461 26.6%   
No. of employees `0006.135.0 17.5%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.324,089.9 37.3%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.3654.1 250.0%   
INCOME DATA
Net Sales Rs m55,144843,147 6.5%  
Other income Rs m1,4440-   
Total revenues Rs m56,588843,147 6.7%   
Gross profit Rs m15,883218,175 7.3%  
Depreciation Rs m4,478157,870 2.8%   
Interest Rs m70940,552 1.7%   
Profit before tax Rs m12,14019,752 61.5%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123-3,142 -67.6%   
Profit after tax Rs m10,02622,895 43.8%  
Gross profit margin %28.825.9 111.3%  
Effective tax rate %17.5-15.9 -109.9%   
Net profit margin %18.22.7 669.6%  
BALANCE SHEET DATA
Current assets Rs m48,228470,812 10.2%   
Current liabilities Rs m30,376343,274 8.8%   
Net working cap to sales %32.415.1 214.0%  
Current ratio x1.61.4 115.8%  
Inventory Days Days6884 81.7%  
Debtors Days Days8693 91.6%  
Net fixed assets Rs m64,130163,557 39.2%   
Share capital Rs m3,000449 668.3%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,980912,131 6.7%   
Long term debt Rs m15,766984,482 1.6%   
Total assets Rs m121,9242,446,689 5.0%  
Interest coverage x18.11.5 1,218.7%   
Debt to equity ratio x0.31.1 24.0%  
Sales to assets ratio x0.50.3 131.2%   
Return on assets %8.82.6 339.5%  
Return on equity %16.42.5 655.0%  
Return on capital %16.83.2 526.9%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546175,206 6.6%  
From Investments Rs m-7,138-90,562 7.9%  
From Financial Activity Rs m-2,417-81,621 3.0%  
Net Cashflow Rs m2,1031,452 144.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: SUVEN LIFE SCIENCES  ORCHID PHARMA  J.B.CHEMICALS  DR. REDDYS LAB  WOCKHARDT  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Apr 16, 2021 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 5-YR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS